A model based on six HDAC genes (HDAC1, HDAC3, HDAC4, HDAC5, HDAC7, and HDAC9) can predict the overall survival of glioma patients well and these genes are potential therapeutic targets. The gene discussed is HDAC9; the disease is glioma.